German Merck KGaA Licenses Drug From India's Glenmark Pharmaceuticals; Glenmark To Get 190 Million Euros

FRANKFURT, Oct 17 (Reuters) - Germany's Merck KGaA has licensed a diabetes drug from India's Glenmark Pharmaceuticals , Merck said on Tuesday, beefing up its pipeline and marking another milestone for India's drug sector.

>>> Discuss This Story

Back to news